Atlas Trials

Evaluation of the Safety and Efficacy of NeuroEPO in Subjects With Mild to Moderate Alzheimer's Disease

Clinical trial NCT07178678 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07178678
Sponsor
University of Saskatchewan
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Mild Alzheimer's DiseaseModerate Alzheimer's Disease
Start date
2025-11-01
Primary completion
2030-03-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.